The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene; MSD; Roche Pharma AG
Research Funding - RIEMSER (Inst); Roche Pharma AG (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Celgene; Roche Pharma AG; Takeda
Alemtuzumab added to CHOP for treatment of peripheral T-cell lymphoma (pTNHL) of the elderly: Final results of 116 patients treated in the international ACT-2 phase III trial.
 
Lorenz H. Trumper
Consulting or Advisory Role - Hexal; Janssen-Ortho
Research Funding - Amgen; Genzyme; Mundipharma; Roche/Genentech
 
Gerald Wulf
No Relationships to Disclose
 
Marita Ziepert
No Relationships to Disclose
 
Francesco D'Amore
Honoraria - Bayer Schering Pharma; CTI; Kyowa Hakko Kirin; Nordic Nanovector; SERVIER; Takeda
Consulting or Advisory Role - Bayer Schering Pharma (Inst); CTI (Inst); Kyowa Hakko Kirin (Inst); Nordic nanovector (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
 
Gerhard Held
No Relationships to Disclose
 
Richard Greil
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Novartis; Roche/Genentech
Research Funding - Abbvie; Amgen; ARIAD; Astellas Pharma; Bayer; Pfizer; Sanofi
 
Olivier Tournilhac
Honoraria - Celgene; GlaxoSmithKline; Janssen-Cilag; Mundipharma; Roche
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Mundipharma; Roche
 
Thomas Relander
No Relationships to Disclose
 
Andreas Viardot
Honoraria - Amgen; Janssen-Ortho; Pfizer; Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Gilead Sciences
Travel, Accommodations, Expenses - Janssen-Ortho; Roche/Genentech; Takeda
 
Martin Wilhelm
No Relationships to Disclose
 
Josee M Zijlstra
Consulting or Advisory Role - Celgene (Inst); Merck Sharp & Dohme (Inst); Roche/Genentech (Inst); Takeda (Inst)
Speakers' Bureau - Celgene; Janssen; Roche/Genentech; Takeda
Research Funding - Gilead Sciences (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Roche/Genentech (Inst)
 
Johanna C. Kluin-Nelemans
No Relationships to Disclose
 
Maike Nickelsen
No Relationships to Disclose
 
Friederike Braulke
No Relationships to Disclose
 
Bettina Altmann
No Relationships to Disclose
 
Andreas Rosenwald
Consulting or Advisory Role - MorphoSys
Travel, Accommodations, Expenses - Roche/Genentech
 
Philippe Gaulard
No Relationships to Disclose
 
Markus Loeffler
No Relationships to Disclose
 
Michael Pfreundschuh
Honoraria - Roche/Genentech
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Celgene; Janssen-Ortho
Research Funding - Amgen; Roche/Genentech; Spectrum Pharmaceuticals
 
Norbert Schmitz
No Relationships to Disclose